Long-term calcineurin inhibitor "holiday" using daclizumab in a heart transplant patient with acute renal dysfunction. - Suppr | 超能文献

Long-term calcineurin inhibitor "holiday" using daclizumab in a heart transplant patient with acute renal dysfunction.

作者信息

Potter B, Giannetti N, Cecere R, Cantarovich M

出版信息

J Heart Lung Transplant. 2005 Aug;24(8):1126-8. doi: 10.1016/j.healun.2004.10.002.

DOI:10.1016/j.healun.2004.10.002

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Long-term calcineurin inhibitor "holiday" using daclizumab in a heart transplant patient with acute renal dysfunction.

J Heart Lung Transplant. 2005 Aug;24(8):1126-8. doi: 10.1016/j.healun.2004.10.002.

2

Repeated daclizumab administration to delay the introduction of calcineurin inhibitors in heart transplant patients with postoperative renal dysfunction.重复给予达利珠单抗以延迟具有术后肾功能障碍的心脏移植患者中钙调磷酸酶抑制剂的引入。

Rev Esp Cardiol. 2011 Mar;64(3):237-9. doi: 10.1016/j.recesp.2010.05.001.

3

Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation.

Nephrol Dial Transplant. 2008 Jun;23(6):2091-4. doi: 10.1093/ndt/gfn099. Epub 2008 Mar 4.

4

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.在患有移植相关微血管病或移植物抗宿主病相关肾功能不全的患者中，用达利珠单抗替代钙调神经磷酸酶抑制剂。

Bone Marrow Transplant. 2006 Sep;38(6):445-51. doi: 10.1038/sj.bmt.1705454.

5

Experience with single-dose daclizumab in the prevention of acute rejection in heart transplantation.单剂量达利珠单抗预防心脏移植急性排斥反应的经验。

Transplant Proc. 2005 Nov;37(9):4036-8. doi: 10.1016/j.transproceed.2005.10.086.

6

Following-up of a four-dose daclizumab induction therapy without calcineurin inhibitors in a liver transplantation recipient with severe renal dysfunction: a case report.在一名患有严重肾功能不全的肝移植受者中，不使用钙调神经磷酸酶抑制剂的四剂达利珠单抗诱导治疗的随访：病例报告

Transplant Proc. 2008 Dec;40(10):3819-20. doi: 10.1016/j.transproceed.2008.06.101.

7

[The role of some selected risk factors in the development of the nephrotoxicity of immunosuppressive medications used after the heart transplantation in children and young adults].[某些选定风险因素在儿童和青年心脏移植后使用的免疫抑制药物肾毒性发展中的作用]

Przegl Lek. 2006;63 Suppl 3:40-3.

8

Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients.心脏和肺移植受者中，停用钙调神经磷酸酶抑制剂转换为西罗莫司与剂量最小化及肾脏转归的比较

Clin Transplant. 2009 Jun-Jul;23(3):351-60. doi: 10.1111/j.1399-0012.2009.00963.x. Epub 2009 Feb 5.

9

Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients.在心脏移植患者中，用西罗莫司替代钙调神经磷酸酶抑制剂与减少剂量的钙调神经磷酸酶抑制剂加西罗莫司相比，与肾功能障碍改善相关。

Clin Transplant. 2007 May-Jun;21(3):305-8. doi: 10.1111/j.1399-0012.2006.00632.x.

10

Immunosuppression for heart transplantation: where are we now?心脏移植的免疫抑制：我们目前处于什么阶段？

Nat Clin Pract Cardiovasc Med. 2006 Apr;3(4):203-12. doi: 10.1038/ncpcardio0510.

引用本文的文献

1

Non-Induction Basiliximab to Facilitate Renal Recovery via Temporary Tacrolimus Cessation in Cardiothoracic Transplant Patients.非诱导使用巴利昔单抗通过暂时停用他克莫司促进心胸移植患者的肾功能恢复

Medicines (Basel). 2025 Aug 28;12(3):22. doi: 10.3390/medicines12030022.

2

Immunosuppressive T-cell antibody induction for heart transplant recipients.心脏移植受者的免疫抑制性T细胞抗体诱导治疗

Cochrane Database Syst Rev. 2013 Dec 2;2013(12):CD008842. doi: 10.1002/14651858.CD008842.pub2.